BI
BIOVENTRIX, INC.
SEC filingOther · Mansfield, MA
Amount raised$3Msold at filing
Total offering$10M$7M still open
Investors in the raise25count reported to the SEC
FiledSep 9, 2026first sale Apr 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David RichmondExecutive Officer, Director
Steven ChartierExecutive Officer, Director
William T. AbrahamDirector
Rishi PuriDirector
Executive officers, directors and promoters as listed on the Form D.